Press Releases

JOHANNESBURG, May 2, 2024 /PRNewswire/ -- Shareholders are advised in terms of paragraph 3.59 of the JSE Listings Requirements that Mr Hanré Rossouw has informed the Company that he will step down as Chief Financial Officer and executive director of Sasol Limited on 31 October 2024.

Mr Steve Westwell, the Chairman of Sasol, said: "Hanré joined Sasol on 4 April 2022 and has made a solid contribution towards achieving Future Sasol." Ms Trix Kennealy, Chairman of... (continue reading...)

 Distinguished for Innovative Design Excellence in UI/UX and Product Design

BENGALURU, India, May 2, 2024 /PRNewswire/ --Tata Elxsi, a global leader in design and technology services, has won two iF DESIGN AWARDs in User Experience Design, for its Sports and Entertainment OTT Experience solution, and Product Design, for the 'Aha!' Tea Vending Machine for Chaayos.

... (continue reading...)

The strategic move is a result of the joint venture's runaway success and comes at a time when Aptoide is launching its innovative combined iOS and Android app distribution

LISBON, Portugal, May 2, 2024 /PRNewswire/ -- Aptoide, the leading alternative app distribution platform, has announced the sale of its participation in Faurecia Aptoide Automotive to Forvia, a key player in the automotive industry, in a significant strategic move that illustrates the runaway... (continue reading...)

Company announcement 12/2024

Green Hydrogen Systems announces issuance of warrants to executive management and key employees

Kolding, Denmark, 1 May 2024 – Green Hydrogen Systems A/S (“Company”) announces the decision to issue warrants for executive management and key employees, who are in a non-terminated position and who were employed on 1 April 2024. The warrant program is established as a long-term incentive scheme reflecting the Company’s... (continue reading...)

Planegg/Martinsried, May 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, presented superior T cell receptor engineered T (TCR-T) cell functionality upon combination of optimal affinity 3S (sensitive, specific and safe) TCRs with the PD1-41BB costimulatory switch protein (CSP) at the 7th International Neoantigen Summit... (continue reading...)